ConductScience.org, home

Paper8985016

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.

Jang M and 11 others. Science, 1997. Cited by 3,533 papers, by iCite.

Cite this record

ConductScience Library. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Papers, record 8985016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8985016

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
PubMed
Journal
Science
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
3,533
iCite
Relative citation ratio, by iCite
98.1
iCite
Revised in PubMed
2022-04-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jang MM
2Cai LL
3Udeani GOG O
4Slowing KVK V
5Thomas CFC F
6Beecher CWC W
7Fong HHH H
8Farnsworth NRN R
9Kinghorn ADA D
10Mehta RGR G
11Moon RCR C
12Pezzuto JMJ M

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anticarcinogenic AgentsMajor topic
FruitMajor topic
Neoplasms, ExperimentalMajor topic
StilbenesMajor topic
Animals
Anti-Inflammatory Agents, Non-Steroidal
Antimutagenic Agents
Carcinogens
Cell Differentiation
Cyclooxygenase 1
Cyclooxygenase Inhibitors
Female
Humans
Inflammation
Isoenzymes
Mammary Neoplasms, Experimental
Membrane Proteins
Mice
Peroxidases
Precancerous Conditions
Prostaglandin-Endoperoxide Synthases
Rats
Rats, Wistar
Resveratrol
Skin Neoplasms
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA48112NCI NIH HHSUnited StatesP01CA048112PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by1,144

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3,533 citations.

PMIDTitleJournalYearIn PapersSource
42968626Resveratrol Modulates Bone Metabolism Through SIRT1-Mediated NF-κB Inhibition: Molecular Mechanisms and Therapeutic Implications.Cell Biochem Funct2026https://conductscience.org/library/papers/42968626PubMed
42940323Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study.Foods2026https://conductscience.org/library/papers/42940323PubMed
42921159Natural compounds as potential countermeasures for spaceflight-associated neuro-ocular syndrome.Front Ophthalmol (Lausanne)2026https://conductscience.org/library/papers/42921159PubMed
42861418Alcohol consumption: from biochemistry to behavior, health, and beyond.Front Toxicol2026https://conductscience.org/library/papers/42861418PubMed
42582115Mediterranean diet impact on plasma proteins: biomarker networks linking nutrition to the modulation of inflammation and oxidative stress.Front Nutr2026https://conductscience.org/library/papers/42582115PubMed
42555914Toxicological and Cytogenetic Screening of Strontium Ranelate Alone and in Combination With Resveratrol.Chem Biodivers2026https://conductscience.org/library/papers/42555914PubMed
42451578Natural Source, Chemical Classification and Medicinal Application of the Stilbene-Type Compounds: A Review of Structural Modification Around Stilbene Scaffold.Molecules2026https://conductscience.org/library/papers/42451578PubMed
42221904Research progress on the biosynthesis and regulatory mechanisms of resveratrol in plants.Front Plant Sci2026https://conductscience.org/library/papers/42221904PubMed
42151413Autophagy modulation in cancer.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42151413PubMed
42128977Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation.AAPS J2026https://conductscience.org/library/papers/42128977PubMed
42099748Resveratrol for Cancer Radio-Sensitization: Ready for Prime Time or Future Perspective.Food Sci Nutr2026https://conductscience.org/library/papers/42099748PubMed
42089408Natural xanthones as α-Mangostin induce vasorelaxation involving key gating residues in the S6 domain of BK channels.Elife2026https://conductscience.org/library/papers/42089408PubMed
42006483Resveratrol supplementation as a non-surgical treatment in periodontitis and related systemic conditions.J Tradit Complement Med2026https://conductscience.org/library/papers/42006483PubMed
42006362Thermo-pH dual-responsive nanocarriers enable multiscale-controlled resveratrol release via molecular remodeling and electronic decoupling.iScience2026https://conductscience.org/library/papers/42006362PubMed
41946701A live biohybrid bacterial therapy based on engineered Serratia marcescens.Nat Commun2026https://conductscience.org/library/papers/41946701PubMed
41924450Triphenylphosphonium Bolaamphiphile-Liposomes Loaded with Resveratrol and Trolox: Mitochondriotropic Formulations with Therapeutic Potential in Neurodegeneration and Cancer.Int J Nanomedicine2026https://conductscience.org/library/papers/41924450PubMed
41828789Current State of Knowledge of the Anticancer Properties of Polyphenolic Compounds from Garlic (Allium sativum L.).Molecules2026https://conductscience.org/library/papers/41828789PubMed
41828721Synergistic Anticancer Effects of Vitamin D and Plant-Derived Compounds: Molecular Mechanisms, Therapeutic Potential, and Nanotechnology-Enabled Delivery Approaches.Int J Mol Sci2026https://conductscience.org/library/papers/41828721PubMed
41782655An Updated Narrative Review on the Therapeutic Potential of Resveratrol in the Treatment of Cancer.Health Sci Rep2026https://conductscience.org/library/papers/41782655PubMed
41750262Phytochemicals Possess Selective Chemopreventive Mechanisms That Safeguard Human Cells from Oxidative Toxicity.Biomolecules2026https://conductscience.org/library/papers/41750262PubMed

See all 1,144 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PTGS15742PubTator's text mininghttps://conductscience.org/library/genes/5742NCBI Gene
PTGS25743PubTator's text mininghttps://conductscience.org/library/genes/5743NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8985016

GET https://conductscience.org/api/papers/v1/8985016/cited_by?page=2